Theravance Biopharma Stock News

Catalyst Pharmaceuticals (CPRX) reports preliminary sales figures for the fourth quarter. The company also provides its revenue guidance for 2022.

Lannett (LCI) delivered earnings and revenue surprises of -21.88% and 14.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

DUBLIN, Feb. 2, 2022 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will present at the SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16, at 3:40 pm ET (12:40

Theravance Biopharma Inc (TBPH) shares closed this week 23.8% lower than it did at the end of last week. The stock is currently down 10.6% year-to-date, down 45.1% over the past 12 months, and down 70.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Shares traded as high as $13.17 and as low as $9.26 this week.Trading volume this week was 20.1% lower than the 10-day average and 20.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 37.3% The company's stock price performance over the past 12 months lags the peer average by -1291.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Theravance Biopharma Inc (TBPH) shares closed today 11.1% higher than it did at the end of yesterday. The stock is currently up 11.1% year-to-date, down 30.9% over the past 12 months, and down 62.2% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $13.13 and as low as $10.35 this week.Shares closed 46.0% below its 52-week high and 101.3% above its 52-week low.Trading volume this week was 59.6% lower than the 10-day average and 61.8% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 918.2% The company's stock price performance over the past 12 months lags the peer average by -223.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Investors need to pay close attention to Theravance Biopharma (TBPH) stock based on the movements in the options market lately.

During the last session, Theravance Biopharma Inc. (NASDAQ:TBPH)s traded shares were 1.53 million, with the beta value of the company hitting 0.77. At the end of the trading day, the stocks price was $10.71, reflecting an intraday gain of 4.69% or $0.48. The 52-week high for the TBPH share is $22.74, that puts it down The Theravance Biopharma Inc. (NASDAQ: TBPH) Stock Dropped 30.29% In A Single Month Are There Any Hopes For A Gain? Read More »

The trading price of Theravance Biopharma Inc. (NASDAQ:TBPH) closed higher on Monday, December 13, closing at $10.03, 2.98% higher than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) saw unusually-high trading volume on Thursday . Approximately 44,767 shares traded hands during mid-day trading, a decline of 93% from the previous sessions volume of 655,570 shares.The stock last traded at $9.40 and had previously closed at $9.27. TBPH has been the topic of a number of recent analyst []

Theravance Biopharma, Inc. (NASDAQ:TBPH) traded up 6.6% during mid-day trading on Wednesday . The company traded as high as $9.16 and last traded at $9.10. 10,644 shares were traded during trading, a decline of 98% from the average session volume of 652,680 shares. The stock had previously closed at $8.54. A number of research analysts []

Millennium Management LLC raised its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) by 26.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,551 shares of the biopharmaceutical companys stock after acquiring an additional 31,682 shares during the quarter. Millennium Management LLCs holdings in []

Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Theravance Biopharma, Inc. (NASDAQ:TBPH)s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $8.40, but opened at $7.99. Theravance Biopharma shares last traded at $8.72, with a volume of 5,135 shares. A number of brokerages recently issued reports on TBPH. Morgan Stanley decreased their target price on []

Theravance Biopharma, Inc. (NASDAQ:TBPH)s stock price traded down 5.5% during mid-day trading on Thursday . The stock traded as low as $8.13 and last traded at $8.13. 1,982 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 651,784 shares. The stock had previously closed at $8.60. Several research []